Skip to main content

Table 3 Thermal pain thresholds and pressure pain thresholds among juvenile idiopathic arthritis (JIA) and controls*

From: Pain sensitivity in young adults with juvenile idiopathic arthritis: a quantitative sensory testing study

 

n

Cold pain thresholda

Heat pain threshold

Pressure pain threshold

Absolute temperature °C (95% CI)

Absolute temperature °C (95% CI)

Kilopascal (95% CI)

Upper limb

Lower limb

Upper limb

Lower limb

Upper limb

Lower limb

Control

109

15.9 (13.8, 18.0)

13.2 (11.1, 15.3)

44.3 (43.6, 45.0)

44.9 (44.3, 45.4)

1029 (999, 1059)

760 (726, 794)

JIA (total group)b

96

15.5 (13.1, 17.8)

13.4 (11.1, 15.8)

44.0 (43.1, 44.8)

44.8 (44.2, 45.4)

888 (846, 930)

702 (670, 734)

p = 0.8

p = 0.9

p = 0.5

p = 0.8

p < 0.001

p = 0.01

JIA

 Remission off med.c

43

14.3 (10.7, 17.8)

11.8 (8.2, 15.4)

43.6 (42.2, 45.0)

44.8 (43.8, 45.8)

893 (823, 962)

731 (674, 788)

p = 0.4

p = 0.5

p = 0.4

p = 0.9

p < 0.001

p = 0.4

 Inactive diseasec

20

16.9 (11.9, 22.0)

17.4 (12.4, 22.4)

44.2 (42.4, 46.0)

44.9 (43.5, 46.3)

836 (761, 910)

626 (574, 677)

p = 0.7

p = 0.1

p = 0.9

p = 1.0

p < 0.001

p < 0.001

 Active diseasec

33

16.2 (12.4, 20.0)

13.1 (9.2, 17.0)

44.3 (43.1, 45.4)

44.6 (43.9, 45.3)

910 (842, 978)

707 (662, 752)

p = 0.9

p = 1.0

p = 0.9

p = 0.6

p = 0.002

p = 0.06

  1. *Multilevel modeling with predicted values as absolute temperature with 95% CI, adjusted for age and sex
  2. CI confidence interval, p p value comparing controls with JIA disease group (either total group or according to disease status)
  3. aA substantial number were censored because the participants did not reach their cold pain thresholds due to floor temperature of the hardware was 5 °C; 212 (28%) in the JIA group and 198 (23%) in the control group. We accounted for these censored responses in the statistical analyses
  4. bSeparate multilevel model of the total JIA cohort
  5. cDisease status according to the definition by Wallace et al. Remission off med. remission off medication for ≥ 12 months, Inactive disease inactive disease on medication for less than 6 months or inactive disease off medication for less than 12 months or remission on medication (inactive disease on medication for more than 6 months). Active disease flare or continuous active disease